ENT2 Recombinant Antibody, PE-Cy5.5 Conjugated
Product Specifications
Background
Mediates equilibrative transport of purine, pyrimidine nucleosides and the purine base hypoxanthine. Very less sensitive than SLC29A1 to inhibition by nitrobenzylthioinosine (NBMPR), dipyridamole, dilazep and draflazine.
Synonyms
DER12; ei-type; HNP36; Nucleoside transporter; SLC29A2.
Gene ID
3177
Swiss Prot
Q14542
Cellular Locus
Nucleus, Cell membrane
Host
Rabbit
Cross Reactivity
Human
Target
ENT2
Clonality
Recombinant
Isotype
IgG
Conjugation
PE-Cy5.5
Source
KLH conjugated synthetic peptide derived from human ENT2
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
488nm/694nm
Concentration
Lot dependent
Dilution
WB (1:300-5000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Product Datasheet
https://www.biossantibodies.com/datasheets/bsm-62135R-PE-Cy5.5
Gene ID URL
3177
Predicted Cross Reactivity
Mouse, Rat
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
RC212617L3V 200 µL
CD49b (ITGA2) (NM_002203) Human Tagged ORF Clone Lentiviral Particle
Ask
View Details 
